^
    Contact us  to learn more about
    our Premium Content:  News alerts, weekly reports and conference planners
    DRUG:

    225Ac-FL-020

    i
    Other names: 225Ac-FL-020, [225Ac]Ac-FL-020
    Company:
    Full-Life Technologies Limited
    Drug class:
    Ionizing radiation emitter, PSMA inhibitor
    Related drugs:
    3ms
    Study With [225Ac]Ac-FL-020 in mCRPC Participants (clinicaltrials.gov)
    P1, N=35, Recruiting, Full-Life Technologies GmbH | Not yet recruiting --> Recruiting | Initiation date: Jul 2024 --> Oct 2024
    Enrollment open • Trial initiation date
    |
    225Ac-FL-020
    5ms
    Phase 1 With [225Ac]Ac-FL-020 in mCRPC Participants (clinicaltrials.gov)
    P1, N=35, Not yet recruiting, Full-Life Technologies GmbH
    New P1 trial
    |
    225Ac-FL-020